Braidwell LP Compass Therapeutics, Inc. Transaction History

Braidwell LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.4 - $1.98 $7.89 Million - $11.2 Million	-5,636,512 Reduced 94.66%	317,761 $496 Million
Q2 2023 Aug 14, 2023	BUY	$2.64 - $3.48 $7.14 Million - $9.42 Million	2,706,426 Added 83.33%	5,954,273 $18.9 Billion
Q1 2023 May 15, 2023	BUY	$3.14 - $5.48 $4.5 Million - $7.86 Million	1,433,581 Added 79.02%	3,247,847 $10.6 Billion
Q4 2022 Feb 14, 2023	BUY	$2.55 - $5.41 $4.63 Million - $9.82 Million	1,814,266 New	1,814,266 $9.13 Billion

91.9M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $139M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.